Ogayo, Esther R.
Mittendorf, Elizabeth A.
Kantor, Olga
Article History
Accepted: 15 January 2024
First Online: 3 February 2024
Declarations
:
: EAM reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. ERO and OK report no disclosures.
: This article does not contain any studies with human or animal subjects performed by any of the authors.